Introduction
The United States Endometrial Cancer Market, as outlined in the TechSci Research report titled “United States Endometrial Cancer Market – By Region, Competition, Forecast, and Opportunities, 2028,” was valued at USD 1.09 billion in 2022 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.06% from 2024 to 2028. This dynamic market is situated within the broader healthcare landscape, focusing on the diagnosis, treatment, and management of endometrial cancer—a prevalen